July 28, 2026 - 03:41

Brian Malloy, who had only recently taken the helm at Carpenter Technology, a Philadelphia-based specialty metals manufacturer, has died unexpectedly. He was 59 years old.
Malloy assumed the role of chief executive officer on July 1, succeeding a previous leader. His sudden death on July 24 has sent shockwaves through the company and the broader industrial sector. The cause of death has not been publicly disclosed by the company.
Before joining Carpenter Technology, Malloy spent much of his career in leadership positions at other industrial firms, including a long tenure at a major aerospace and automotive parts supplier. He was widely regarded as a seasoned executive with deep experience in manufacturing and supply chain management.
In a statement, the company's board of directors expressed deep sadness and offered condolences to Malloy's family. They noted his brief tenure was marked by enthusiasm and a clear vision for the company's future. The board has appointed an interim CEO to ensure stability while they conduct a search for a permanent successor.
Carpenter Technology produces high-performance alloys used in the aerospace, defense, and medical industries. The company's stock saw a modest decline in after-hours trading following the announcement. Analysts say the leadership transition is unexpected but note that the company has a strong management team in place to navigate the immediate period.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...